147 related articles for article (PubMed ID: 35891746)
41. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
42. CyclinD1, a prominent prognostic marker for endometrial diseases.
Liang S; Mu K; Wang Y; Zhou Z; Zhang J; Sheng Y; Zhang T
Diagn Pathol; 2013 Aug; 8():138. PubMed ID: 23947899
[TBL] [Abstract][Full Text] [Related]
43. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical evaluation of PTEN protein in patients with endometrial intraepithelial neoplasia compared to endometrial adenocarcinoma and proliferative phase endometrium.
Cirpan T; Terek MC; Mgoyi L; Zekioglu O; Iscan O; Ozsaran A
Eur J Gynaecol Oncol; 2006; 27(4):389-92. PubMed ID: 17009632
[TBL] [Abstract][Full Text] [Related]
45. Endometrial hyperplasia and carcinoma with superimposed secretory changes: a double whammy.
Daya D
Int J Gynecol Pathol; 2014 Mar; 33(2):105-6. PubMed ID: 24487462
[No Abstract] [Full Text] [Related]
46. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
47. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
48. Simple hyperplasia of the endometrium: an evaluation of proliferative activity by Ki-67 immunostaining.
Ambros RA
Int J Gynecol Pathol; 2000 Jul; 19(3):206-11. PubMed ID: 10907167
[TBL] [Abstract][Full Text] [Related]
49. Endometrial eosinophilic syncytial change related to breakdown: immunohistochemical evidence suggests a regressive process.
Shah SS; Mazur MT
Int J Gynecol Pathol; 2008 Oct; 27(4):534-8. PubMed ID: 18753967
[TBL] [Abstract][Full Text] [Related]
50. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
[TBL] [Abstract][Full Text] [Related]
51. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
[TBL] [Abstract][Full Text] [Related]
52. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
53. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
[TBL] [Abstract][Full Text] [Related]
54. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
[TBL] [Abstract][Full Text] [Related]
55. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
[TBL] [Abstract][Full Text] [Related]
56. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
[TBL] [Abstract][Full Text] [Related]
57. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
[TBL] [Abstract][Full Text] [Related]
58. [Preinvasive lesions in gynaecology - endometrium].
Feranec R; Mouková L; Chovanec J
Klin Onkol; 2013; 26 Suppl():S52-3. PubMed ID: 24325166
[TBL] [Abstract][Full Text] [Related]
59. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
Ashton-Sager A; Paulino AF; Afify AM
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
[TBL] [Abstract][Full Text] [Related]
60. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]